UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics

Molecular cancer therapeutics, 2013-02, Vol.12 (2), p.220-229

2013

Link zum Volltext

Verfügbarkeit prüfen

Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers

Clinical cancer research, 2012-11, Vol.18 (22), p.6169-6177

2012

Link zum Volltext

Verfügbarkeit prüfen

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

PLoS medicine, 2005-03, Vol.2 (3), p.e73-e73

2005

Link zum Volltext

Verfügbarkeit prüfen

Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions

Clinical cancer research, 2012-12, Vol.18 (24), p.6599-6608

2012

Link zum Volltext

Verfügbarkeit prüfen

Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing

Journal of thoracic oncology, 2011-03, Vol.6 (3), p.451-458

2011

Link zum Volltext

Verfügbarkeit prüfen

High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507)

PloS one, 2009-10, Vol.4 (10), p.e7273-e7273

2009

Link zum Volltext

Verfügbarkeit prüfen

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

PLoS medicine, 2005-01, Vol.2 (1), p.e17-e17

2005

Link zum Volltext

Verfügbarkeit prüfen

Distinct Clinical Course of EGFR-Mutant Resected Lung Cancers: Results of Testing of 1118 Surgical Specimens and Effects of Adjuvant Gefitinib and Erlotinib

Journal of thoracic oncology, 2012-12, Vol.7 (12), p.1815-1822

2012

Link zum Volltext

Verfügbarkeit prüfen

Subtyping of Non-small Cell Lung Carcinoma: A Comparison of Small Biopsy and Cytology Specimens

Journal of thoracic oncology, 2011-11, Vol.6 (11), p.1849-1856

2011

Link zum Volltext

Verfügbarkeit prüfen

Global gene expression profiling of pleural mesotheliomas : Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (6), p.2970-2979

2006

Link zum Volltext

Verfügbarkeit prüfen

Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans

Journal of thoracic oncology, 2011-01, Vol.6 (1), p.28-31

2011

Link zum Volltext

Verfügbarkeit prüfen

Homozygous Deletion of CDKN2A and Codeletion of the Methylthioadenosine Phosphorylase Gene in the Majority of Pleural Mesotheliomas

Clinical cancer research, 2003-06, Vol.9 (6), p.2108-2113

2003

Link zum Volltext

Verfügbarkeit prüfen

The diagnosis of malignant mesothelioma in effusion cytology

Cancer cytopathology, 2013-12, Vol.121 (12), p.703-707

2013

Link zum Volltext

Verfügbarkeit prüfen

Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas

Lung cancer (Amsterdam, Netherlands), 2012-03, Vol.75 (3), p.332-335

2012

Link zum Volltext

Verfügbarkeit prüfen

Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas

Cancer discovery, 2013-06, Vol.3 (6), p.630-635

2013

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary Toxicity Associated With Erlotinib

Chest, 2007-09, Vol.132 (3), p.1042-1044

2007

Link zum Volltext

Verfügbarkeit prüfen

Insulin-Like Growth Factor-1 Receptor Expression in Thymic Malignancies

Journal of thoracic oncology, 2010-09, Vol.5 (9), p.1439-1446

2010

Link zum Volltext

Verfügbarkeit prüfen

The Role of Fine Needle Aspiration Cytology in the Diagnosis and Management of Thymic Neoplasia

Journal of thoracic oncology, 2010-10, Vol.5 (10), p.S281-S285

2010

Link zum Volltext

Verfügbarkeit prüfen

Analytic inquiry: Molecular testing in lung cancer

Cancer cytopathology, 2017-06, Vol.125 (S6), p.470-476

Zakowski, Maureen F.

2017

Link zum Volltext

Verfügbarkeit prüfen

Aspiration Cytomorphology of Fetal Adenocarcinoma of the Lung

American journal of clinical pathology, 2010-12, Vol.134 (6), p.894-902

2010

Link zum Volltext

Verfügbarkeit prüfen

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions

Cancer, 2003-02, Vol.99 (1), p.51-56

2003

Link zum Volltext

Verfügbarkeit prüfen

Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors

Genes & development, 2006-06, Vol.20 (11), p.1496-1510

2006

Link zum Volltext

Verfügbarkeit prüfen

Cytology nomenclature and 2015 World Health Organization classification of lung cancer

Cancer cytopathology, 2016-02, Vol.124 (2), p.81-88

Zakowski, Maureen F.

2016

Link zum Volltext

Verfügbarkeit prüfen

Use of thyroid transcription factor 1, PE‐10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine‐needle aspiration biopsy specimens

Cancer, 2001-10, Vol.93 (5), p.330-336

2001

Link zum Volltext

Verfügbarkeit prüfen

“…That which we call a rose…”: A critical analysis of rapid on‐site evaluation

Cancer cytopathology, 2016-12, Vol.124 (12), p.857-861

Zakowski, Maureen F.

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 138

Suche als RSS-Feed

Aktive Filter

ThemaMutation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Englisch
(138)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

Humans
(89)
Science & Technology
(85)
Life Sciences & Biomedicine
(83)
Female
(58)
Male
(51)
Medical Sciences
(49)
Biological And Medical Sciences
(48)
Middle Aged
(47)
Oncology
(46)
Pathology
(44)
Adult
(42)
Aged
(42)
Cytology
(28)
Lung Neoplasms - Pathology
(26)
Aged, 80 And Over
(24)
Respiratory System
(24)
Investigative Techniques, Diagnostic Techniques
(23)
Retrospective Studies
(21)
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous Investigative Techniques
(20)
Diagnosis, Differential
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics

Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions

Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing

High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507)

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

Distinct Clinical Course of EGFR-Mutant Resected Lung Cancers: Results of Testing of 1118 Surgical Specimens and Effects of Adjuvant Gefitinib and Erlotinib

Subtyping of Non-small Cell Lung Carcinoma: A Comparison of Small Biopsy and Cytology Specimens

Global gene expression profiling of pleural mesotheliomas : Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction

Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans

Homozygous Deletion of CDKN2A and Codeletion of the Methylthioadenosine Phosphorylase Gene in the Majority of Pleural Mesotheliomas

The diagnosis of malignant mesothelioma in effusion cytology

Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas

Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas

Pulmonary Toxicity Associated With Erlotinib

Insulin-Like Growth Factor-1 Receptor Expression in Thymic Malignancies

The Role of Fine Needle Aspiration Cytology in the Diagnosis and Management of Thymic Neoplasia

Analytic inquiry: Molecular testing in lung cancer

Aspiration Cytomorphology of Fetal Adenocarcinoma of the Lung

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions

Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors

Cytology nomenclature and 2015 World Health Organization classification of lung cancer

Use of thyroid transcription factor 1, PE‐10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine‐needle aspiration biopsy specimens

“…That which we call a rose…”: A critical analysis of rapid on‐site evaluation

Aktive Filter

Suchergebnisse filtern